Versigent CEO granted 111,698 new shares
Liotine Joseph T. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Liotine Joseph T. reported acquisition or exercise transactions in this Form 4 filing.
Versigent PLC disclosed that CEO and director Joseph T. Liotine received a grant of 111,698 Ordinary Shares on April 22, 2026. The award was recorded at a price of $0.00 per share, indicating it is a compensation-related equity grant rather than an open-market purchase. Following this grant, Liotine directly holds 230,153 Ordinary Shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 111,698 | $0.00 | $0.00 |
Key Figures
Key Terms
Grant, award, or other acquisition financial
non-derivative financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Versigent (VGNT) report for Joseph T. Liotine?
Was the Versigent (VGNT) CEO’s Form 4 transaction a stock purchase or a grant?
What does transaction code A mean in the Versigent (VGNT) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.